SCHEMBL8551200

SCHEMBL8551200

CCC(=O)c1ccc(N2CCNCC2)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.59
USP2 O75604 1/20 0.59
TSHR P16473 1/20 0.59
HSD17B10 Q99714 1/20 0.59
ADRB1 P08588 5/20 0.53
MAOB P27338 2/20 0.49
HTR3E A5X5Y0 3/20 0.49
HTR3B O95264 3/20 0.49
HTR3A P46098 3/20 0.49
HTR3D Q70Z44 3/20 0.49
HTR3C Q8WXA8 3/20 0.49
SIGMAR1 Q99720 3/20 0.49
ACVR1 Q04771 1/20 0.48
GSK3B P49841 1/20 0.47
KDM4E B2RXH2 1/20 0.46
LMNA P02545 1/20 0.46
SIRT6 Q8N6T7 1/20 0.46
MAPT P10636 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
ABCB1 P08183 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5233397 0.94 ALDH1A1 (0.54) ALDH1A1USP2TSHRHSD17B10ADRB1
SCHEMBL3342329 0.87 ALDH1A1 (0.56) ALDH1A1USP2TSHRHSD17B10ADRB1
SCHEMBL25803069 0.86 ALDH1A1 (0.63) ALDH1A1USP2TSHRHSD17B10ADRB1
SCHEMBL10505311 0.84 HTT (0.61) ALDH1A1TSHRHSD17B10GSK3BKDM4E
SCHEMBL16564077 0.84 HTT (0.57) ALDH1A1TSHRHSD17B10GSK3BKDM4E
SCHEMBL14123719 0.83 GSK3B (0.69) ALDH1A1USP2TSHRHSD17B10ADRB1
SCHEMBL2201934 0.83 HTT (0.64) ALDH1A1TSHRHSD17B10GSK3BKDM4E
SCHEMBL21477423 0.83 ALDH1A1 (0.55) ALDH1A1USP2TSHRHSD17B10ADRB1
Bromide SCHEMBL14054623 0.82 GSK3B (0.67) ALDH1A1USP2TSHRHSD17B10ADRB1
Bromide SCHEMBL8084816 0.82 GSK3B (0.67) ALDH1A1USP2TSHRHSD17B10ADRB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 17 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101193867-A N-substituted benzimidazolyl c-Kit inhibitors and combinatorial benzimidazole libraries OSI PHARM INC (US) 2008-06-04 CN claimed
CN-102533002-B Solid ink containing ketone wax and side chain acid amides Xerox Corp. (US) Patent Dept. 020 Xerox Square 100 Clinton Avenue Rochester New (US) 2016-01-27 CN disclosed
CN-103936650-B Acid imide Phenylpiperazine derivatives and salt, preparation method and purposes GUANGZHOU MEDICAL UNIVERSITY (CN) 2016-01-20 CN disclosed
CN-102234457-B Fluorescent ink compositions and fluorescent particles XEROX CORP 2014-12-24 CN disclosed
CN-101899238-B Method of making a pigmented phase change ink with dispersant and synergist Xerox Corp. (US) Patent Dept. 020 Xerox Square 100 Clinton Avenue Rochester New (US) 2014-10-01 CN disclosed
CN-103936650-A Imide phenylpiperazine derivatives as well as salts, preparation method and application of imide phenylpiperazine derivatives UNIV GUANGZHOU MEDICAL 2014-07-23 CN disclosed
CN-101460237-B Modified membrane DOW GLOBAL TECHNOLOGIES INC 2013-09-04 CN disclosed
CN-102234457-A Fluorescent ink compositions and fluorescent particles XEROX CORP 2011-11-09 CN disclosed
CN-101460237-A Modified membrane DOW GLOBAL TECHNOLOGIES INC (US) 2009-06-17 CN disclosed
CN-101378757-A Thiadiazole derivatives for the treatment of neuro degenerative diseases REMYND NV (BE) 2009-03-04 CN disclosed
CN-101193867-A N-substituted benzimidazolyl c-Kit inhibitors and combinatorial benzimidazole libraries OSI PHARM INC (US) 2008-06-04 CN disclosed
CN-1243567-C Growth hormone secretagogues LILLY CO ELI (US) 2006-03-01 CN disclosed
CN-1553900-A Acylsemicarbazides as cyclin dependent kinase inhibitors useful as anti-cancer and anti-proliferative agents ��ʱ��ʩ����ҩ��˾ 2004-12-08 CN disclosed
CN-1276727-A Growth hormone secretagogues LILLY CO ELI (US) 2000-12-13 CN disclosed
CN-1251523-A Sulfonamide derivatives LILLY CO ELI (US) 2000-04-26 CN disclosed
EP-0836599-A1 1,6-DISUBSTITUTED ISOCHROMANS FOR TREATMENT OF MIGRAINE HEADACHES PHARMACIA & UPJOHN COMPANY (US) 1998-04-22 EP disclosed
WO-1997002259-A1 1,6-DISUBSTITUTED ISOCHROMANS FOR TREATMENT OF MIGRAINE HEADACHES PHARMACIA & UPJOHN COMPANY (US) 1997-01-23 WO disclosed